WAYNE, Pa., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (TFX) (NYSE:TFX), a leading global provider of medical technologies, announced today that a new peer-reviewed study in the Nature ...
Two Head-to-Head Randomized Trials Highlight Superior Early Patient Experience with the UroLift™ System for BPH 1-2 First-Ever Analysis Utilizing the American Urological Association Quality Registry ...
Teleflex TFX banks on strong UroLift system prospects. The Vascular Solutions business has been contributing to the company’s top line quite handsomely. Yet, escalating operating expenses are putting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results